FDA Asks for Ideas on Protecting Food from Sabotage
Published Date: 7/2/2025
Notice
Summary
The FDA wants your thoughts on how they collect info to keep our food safe from bad stuff added on purpose. Food businesses will be affected as the agency looks to improve rules and make sure everyone’s playing fair. You’ve got 60 days to share your ideas, and this helps keep food safe without costing too much time or money.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
FDA Seeks Comments on Food Safety
The FDA is asking for public comment for 60 days on proposed information collections about mitigation strategies to protect food against intentional adulteration. The agency says this work aims to strengthen protections against deliberate contamination of the food supply.
Food Businesses Will Provide Information
Food businesses will be affected by FDA’s proposed collection of information about mitigation strategies to prevent intentional adulteration. The agency says it aims to improve rules and ensure fairness while not costing too much time or money, and it is requesting comments for 60 days.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2025-12307, Agency Information Collection Activities; Proposed Collection; Comment Request; Environmental Impact Considerations
The FDA wants your thoughts on how it collects info about environmental impacts. This is a chance for anyone affected—like businesses and the public—to share feedback before the agency updates its forms. You’ve got 60 days to weigh in, and no new costs are expected right now.
Next: 2025-12310, Product Change-Priority Mail, and USPS Ground Advantage Negotiated Service Agreements; Priority Mail Negotiated Service Agreements
The Postal Service is updating its shipping deals by adding a new contract for Priority Mail and USPS Ground Advantage services. This change affects businesses using these special shipping agreements and could impact shipping costs and options soon. Keep an eye out for when these new deals kick in—they’re designed to make shipping smoother and possibly save money!